Literature DB >> 6147209

n-Electrode three-dimensional liquid chromatography with electrochemical detection for determination of neurotransmitters.

W R Matson, P Langlais, L Volicer, P H Gamache, E Bird, K A Mark.   

Abstract

Coulometric electrodes in series have been used with liquid chromatography with electrochemical detection to increase selectivity and resolution for the direct analysis of tissue neurotransmitters. Use of three coulometric sensors for electrochemical modification, selectivity, and peak identification has been expanded into "gate" cells of three or four coulometric electrodes that allow elimination of all electrochemically irreversible substances, and "array" cells of up to 15 coulometric electrodes for separation of co-eluting compounds by their current/voltage characteristics. On-column sensitivity of the sensor arrays is 0.4 to 4 pg. Gate cell selectivity favors electrochemically reversible compounds over irreversible ones, e.g., 3-methoxy-4-hydroxyphenylglycol vs ascorbate, by a factor of up to 10(4). Resolution across the multi-electrode array cells allows separation of co-eluting compounds with half-wave potentials differing by as little as 30 to 40 mV. Cells with three to 15 electrodes have been used to measure monoamines and metabolites in brain; monoamines directly in serum filtrate; and the state of oxidation of 5-hydroxytryptamine and 5-hydroxytryptophan in cerebrospinal fluid of patients with Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6147209

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  24 in total

1.  Clinical chemistry through Clinical Chemistry: a journal timeline.

Authors:  Robert Rej
Journal:  Clin Chem       Date:  2004-12       Impact factor: 8.327

2.  Identification of metabolites from liquid chromatography-coulometric array detection profiling: gas chromatography-mass spectrometry and refractionation provide essential information orthogonal to LC-MS/microNMR.

Authors:  Rose M Gathungu; Susan S Bird; Diane P Sheldon; Roger Kautz; Paul Vouros; Wayne R Matson; Bruce S Kristal
Journal:  Anal Biochem       Date:  2014-03-18       Impact factor: 3.365

3.  Metabolomic analysis and signatures in motor neuron disease.

Authors:  Steve Rozen; Merit E Cudkowicz; Mikhail Bogdanov; Wayne R Matson; Bruce S Kristal; Chris Beecher; Scott Harrison; Paul Vouros; Jimmy Flarakos; Karen Vigneau-Callahan; Theodore D Matson; Kristyn M Newhall; M Flint Beal; Robert H Brown; Rima Kaddurah-Daouk
Journal:  Metabolomics       Date:  2005       Impact factor: 4.290

4.  CSF xanthine, homovanillic acid, and their ratio as biomarkers of Parkinson's disease.

Authors:  Peter LeWitt; Lonni Schultz; Peggy Auinger; Mei Lu
Journal:  Brain Res       Date:  2011-07-01       Impact factor: 3.252

5.  Cognitive enhancement in Korsakoff's psychosis by clonidine: a comparison with L-dopa and ephedrine.

Authors:  R G Mair; W J McEntee
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

6.  Grafting fibroblasts genetically modified to produce L-dopa in a rat model of Parkinson disease.

Authors:  J A Wolff; L J Fisher; L Xu; H A Jinnah; P J Langlais; P M Iuvone; K L O'Malley; M B Rosenberg; S Shimohama; T Friedmann
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

7.  Associations between central nervous system serotonin, fasting glucose, and hostility in African American females.

Authors:  Stephen H Boyle; Anastasia Georgiades; Beverly H Brummett; John C Barefoot; Ilene C Siegler; Wayne R Matson; Cynthia M Kuhn; Katherine Grichnik; Mark Stafford-Smith; Redford B Williams; Rima Kaddurah-Daouk; Richard S Surwit
Journal:  Ann Behav Med       Date:  2015-02

8.  Applications of cold temperature stress to age fractionate Caenorhabditis elegans: a simple inexpensive technique.

Authors:  James D Willett; Neeraja Podugu; Gita Sudama; John J Kopecky; Jenefir Isbister
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2010-03-30       Impact factor: 6.053

9.  Monoamines in the brain cerebrospinal fluid of facial pain patients.

Authors:  A J Bouckoms; W H Sweet; C Poletti; P Lavori; D Carr; W Matson; P Gamache; N Aronin
Journal:  Anesth Prog       Date:  1992

10.  A small-molecule therapeutic lead for Huntington's disease: preclinical pharmacology and efficacy of C2-8 in the R6/2 transgenic mouse.

Authors:  Vanita Chopra; Jonathan H Fox; Greg Lieberman; Kathryn Dorsey; Wayne Matson; Peter Waldmeier; David E Housman; Aleksey Kazantsev; Anne B Young; Steven Hersch
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.